TY - JOUR
T1 - Gene network profiling in muscle-invasive bladder cancer
T2 - A systematic review and meta-analysis
AU - Isali, Ilaha
AU - McClellan, Phillip
AU - Calaway, Adam
AU - Prunty, Megan
AU - Abbosh, Phillip
AU - Mishra, Kirtishri
AU - Ponsky, Lee
AU - Markt, Sarah
AU - Psutka, Sarah P.
AU - Bukavina, Laura
N1 - Copyright © 2021 Elsevier Inc. All rights reserved.
PY - 2022/5
Y1 - 2022/5
N2 - Background: Determining meta-analysis of transcriptional profiling of muscle-invasive bladder cancer (MIBC) through Gene Expression Omnibus (GEO) datasets has not been investigated. This study aims to define gene expression profiles in MIBC and to identify potential candidate genes and pathways. Objectives: To review and evaluate gene expression studies in MIBC through publicly available RNA sequencing (RNA-Seq) and microarray data in order to identify potential prognostic and therapeutic targets for MIBC. Methods: A systematic literature search of the Ovid MEDLINE, PubMed, and Wiley Cochrane Central Register of Controlled Trials databases was performed using the terms “gene,” “gene expression,” and “bladder cancer” January 1, 1990 through March 2021 focused on populations with MIBC. Results: In the final analysis, GEO datasets were included. Fixed effect model was employed in the meta-analysis. Gene networking connections and gene-set functional analyses of the identified genes as differentially expressed in MIBC were performed using ImaGEO and GeneMANIA software. A heatmap for the upregulated and downregulated genes was generated along with the correlated pathways. Conclusion: A total of 9 genes were reported in this analysis. Six genes were reported as upregulated (ProTα, SPINT1, UBE2E1, RAB25, KPNB1, HDAC1) and 3 genes as downregulated (NUP188, IPO13, NUP124). Genes were found to be involved in “ubiquitin mediated proteolysis,” “protein processing in endoplasmic reticulum,” “transcriptional misregulation in cancer,” and “RNA transport” pathways.
AB - Background: Determining meta-analysis of transcriptional profiling of muscle-invasive bladder cancer (MIBC) through Gene Expression Omnibus (GEO) datasets has not been investigated. This study aims to define gene expression profiles in MIBC and to identify potential candidate genes and pathways. Objectives: To review and evaluate gene expression studies in MIBC through publicly available RNA sequencing (RNA-Seq) and microarray data in order to identify potential prognostic and therapeutic targets for MIBC. Methods: A systematic literature search of the Ovid MEDLINE, PubMed, and Wiley Cochrane Central Register of Controlled Trials databases was performed using the terms “gene,” “gene expression,” and “bladder cancer” January 1, 1990 through March 2021 focused on populations with MIBC. Results: In the final analysis, GEO datasets were included. Fixed effect model was employed in the meta-analysis. Gene networking connections and gene-set functional analyses of the identified genes as differentially expressed in MIBC were performed using ImaGEO and GeneMANIA software. A heatmap for the upregulated and downregulated genes was generated along with the correlated pathways. Conclusion: A total of 9 genes were reported in this analysis. Six genes were reported as upregulated (ProTα, SPINT1, UBE2E1, RAB25, KPNB1, HDAC1) and 3 genes as downregulated (NUP188, IPO13, NUP124). Genes were found to be involved in “ubiquitin mediated proteolysis,” “protein processing in endoplasmic reticulum,” “transcriptional misregulation in cancer,” and “RNA transport” pathways.
KW - Female
KW - Gene Expression Profiling
KW - Gene Regulatory Networks
KW - Humans
KW - Male
KW - Muscles
KW - Neoplasm Invasiveness
KW - Prognosis
KW - Urinary Bladder Neoplasms/genetics
KW - rab GTP-Binding Proteins/genetics
UR - http://www.scopus.com/inward/record.url?scp=85122943200&partnerID=8YFLogxK
U2 - 10.1016/j.urolonc.2021.11.003
DO - 10.1016/j.urolonc.2021.11.003
M3 - Article
C2 - 35039218
SN - 1078-1439
VL - 40
SP - 197.e11-197.e23
JO - Urologic Oncology: Seminars and Original Investigations
JF - Urologic Oncology: Seminars and Original Investigations
IS - 5
ER -